nanoparticles in aqueous solution were performed with the cubic box, respectively. The last 10 ns 1 equilibrated trajectory was further used to assess the structures and energies. All the calculations 2 were employed by using GROMACS 4.5.5 [3] in the NPT ensemble. A 40 fs time step is used to were chosen to evaluate the anticancer effects of Gd(DTPA-CPT) nanoparticles by MTT assay.
13
Meanwhile, the free drug CPT, Gd(DTPA) and CPT/Gd(DTPA) mixture were used as controls. The CPT, Gd(DTPA) and CPT/Gd(DTPA) mixture. The cells without any treatment were set as control.
18
For Lovo cells, the cells were cultured for another 24 h, 48 h and 72 h at 37 °C under 5% CO 2 ,
19
respectively. For HepG2 cells, the cells were cultured for another 48 h at 37 °C under 5% CO 2 .
20
Thereafter, 20 µL of MTT assay stock solution (5 mg mL -1 in PBS) was added to each well and the 21 cells were incubated for another 4 h. Then culture medium was removed and 200 µL DMSO was the absorbance of each well was measured in a BioTek ® Synergy H4 at a wavelength of 490 nm. were incubated at 37 °C for 3 h. Then the culture medium was removed and the cells were rinsed 7 with PBS three times and fixed with 4% paraformaldehyde for 30 min at room temperature. Nikon Ti-E inverted motorized microscope.
12
Flow cytometry: For flow cytometry, LoVo cells were seeded in 6-well plates at a density of the samples were analyzed by BD Accuri™ C6 flow cytometer to acquire 10,000 events per sample.
5
Finally, the cell populations were analyzed with the FlowJo software.
6
Hemolysis assay: 10 mL of blood from the ear artery of a male New Zealand white rabbit was from 0.5 to 2.5 mM in water were measured. The Gd concentration was measured using ICP-AES.
8
Longitudinal relaxivity (r 1 ) was calculated as the slope of 1/T 1 vs the concentration of Gd.
9
According to the theory for MRI contrast agent, the overall measured relaxivity (R 1 obs ) is a the coordination between the Gd 3+ and carboxylic ion. 
